Injecting drug use among gay and bisexual men in New Zealand: Findings from national human immunodeficiency virus epidemiological and behavioural surveillance

2020 ◽  
Vol 39 (4) ◽  
pp. 365-374
Author(s):  
Peter J. W. Saxton ◽  
Susan M. McAllister ◽  
Geoffrey E. Noller ◽  
David A. L. Newcombe ◽  
Kathryn A. Leafe
Keyword(s):  
Human Immunodeficiency Virus ◽  
New Zealand ◽  
Drug Use ◽  
Gay And Bisexual Men ◽  
Injecting Drug Use ◽  
Bisexual Men ◽  
National Human ◽  
Behavioural Surveillance ◽  
Immunodeficiency Virus ◽  
And Bisexual

scholarly journals Sex trade involvement and rates of human immunodeficiency virus positivity among young gay and bisexual men

2001 ◽  
Vol 30 (6) ◽  
pp. 1449-1454 ◽  
Author(s):  
Amy E Weber ◽  
Kevin JP Craib ◽  
Keith Chan ◽  
Steve Martindale ◽  
Mary Lou Miller ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Gay And Bisexual Men ◽  
Bisexual Men ◽  
Sex Trade ◽  
Immunodeficiency Virus ◽  
And Bisexual

scholarly journals Correlates and subgroups of injecting drug use in UK gay and bisexual men: Findings from the 2014 Gay Men’s Sex Survey

2018 ◽  
Vol 187 ◽  
pp. 292-295 ◽  
Author(s):  
G.J. Melendez-Torres ◽  
Adam Bourne ◽  
Ford Hickson ◽  
David Reid ◽  
Peter Weatherburn
Keyword(s):  
Drug Use ◽  
Gay And Bisexual Men ◽  
Injecting Drug Use ◽  
Bisexual Men ◽  
And Bisexual

Injecting drug use among gay and bisexual men in Sydney: prevalence and associations with sexual risk practices and HIV and hepatitis C infection

2013 ◽  
Vol 17 (4) ◽  
pp. 1344-1351 ◽  
Author(s):  
Toby Lea ◽  
Limin Mao ◽  
Nicky Bath ◽  
Garrett Prestage ◽  
Iryna Zablotska ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Drug Use ◽  
Sexual Risk ◽  
Gay And Bisexual Men ◽  
Injecting Drug Use ◽  
Bisexual Men ◽  
Hepatitis C Infection ◽  
Risk Practices ◽  
And Bisexual

scholarly journals Prevalence and correlates of recent injecting drug use among gay and bisexual men in Australia: Results from the FLUX study

2018 ◽  
Vol 55 ◽  
pp. 222-230 ◽  
Author(s):  
H. Bui ◽  
I. Zablotska-Manos ◽  
M. Hammoud ◽  
F. Jin ◽  
T. Lea ◽  
...  
Keyword(s):  
Drug Use ◽  
Gay And Bisexual Men ◽  
Injecting Drug Use ◽  
Bisexual Men ◽  
And Bisexual

scholarly journals Can Australia Reach the World Health Organization Hepatitis C Elimination Goal by 2025 Among Human Immunodeficiency Virus–positive Gay and Bisexual Men?

2019 ◽  
Vol 70 (1) ◽  
pp. 106-113 ◽  
Author(s):  
David C Boettiger ◽  
Luisa Salazar-Vizcaya ◽  
Gregory J Dore ◽  
Richard T Gray ◽  
Matthew G Law ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Hepatitis C ◽  
Gay And Bisexual Men ◽  
World Health ◽  
Hiv Positive ◽  
Bisexual Men ◽  
Immunodeficiency Virus ◽  
The World ◽  
Hcv Transmission ◽  
And Bisexual

Abstract Background Human immunodeficiency virus (HIV)–positive gay and bisexual men (GBM) in Australia are well engaged in care. The World Health Organization’s (WHO) hepatitis C virus (HCV) elimination target of an 80% reduction in incidence by 2030 may be reachable ahead of time in this population. Methods We predicted the effect of treatment and behavioral changes on HCV incidence among HIV-positive GBM up to 2025 using a HCV transmission model parameterized with Australian data. We assessed the impact of changes in behavior that facilitate HCV transmission in the context of different rates of direct-acting antiviral (DAA) use. Results HCV incidence in our model increased from 0.7 per 100 person-years in 2000 to 2.5 per 100 person-years in 2016 and had the same trajectory as previously reported clinical data. If the proportion of eligible (HCV RNA positive) patients using DAAs stays at 65% per year between 2016 and 2025, with high-risk sexual behavior and injecting drug use remaining at current levels, HCV incidence would drop to 0.4 per 100 person-years (85% decline from 2016). In the same treatment scenario but with substantial increases in risk behavior, HCV incidence would drop to 0.6 per 100 person-years (76% decline). If the proportion of eligible patients using DAAs dropped from 65% per year in 2016 to 20% per year in 2025 and risk behavior did not change, HCV incidence would drop to 0.7 per 100 person-years (70% reduction). Conclusions Reaching the WHO HCV elimination target by 2025 among HIV-positive GBM in Australia is achievable.

Sign in / Sign up

Export Citation Format

Share Document